| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0720 |
|
448 |
340 |
$54K |
| 99499 |
|
811 |
544 |
$38K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
651 |
430 |
$18K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
153 |
150 |
$17K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,089 |
1,054 |
$15K |
| 59025 |
Fetal non-stress test |
699 |
411 |
$8K |
| 73110 |
|
399 |
375 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
271 |
263 |
$8K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
196 |
177 |
$8K |
| 76801 |
|
194 |
155 |
$7K |
| 0510 |
|
256 |
234 |
$4K |
| 73610 |
|
234 |
225 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,271 |
1,152 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$3K |
| 73630 |
|
177 |
171 |
$3K |
| 73130 |
|
172 |
157 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
699 |
681 |
$2K |
| 99070 |
|
533 |
400 |
$2K |
| 73080 |
|
101 |
92 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
93 |
82 |
$2K |
| 80053 |
Comprehensive metabolic panel |
991 |
885 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
388 |
354 |
$1K |
| 86941 |
|
214 |
180 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
375 |
347 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
377 |
347 |
$1K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13 |
12 |
$1K |
| 81001 |
|
707 |
626 |
$840.91 |
| 84443 |
Thyroid stimulating hormone (TSH) |
626 |
588 |
$740.49 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
344 |
324 |
$737.37 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
36 |
35 |
$687.55 |
| 86850 |
|
244 |
208 |
$670.66 |
| 84702 |
|
98 |
71 |
$670.43 |
| 73564 |
|
41 |
41 |
$669.94 |
| 73090 |
|
42 |
40 |
$658.54 |
| 80076 |
|
196 |
179 |
$608.59 |
| 85730 |
|
231 |
218 |
$578.97 |
| 80074 |
|
277 |
252 |
$571.91 |
| 73590 |
|
27 |
25 |
$540.80 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
209 |
191 |
$512.83 |
| 85610 |
|
311 |
289 |
$497.88 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
73 |
70 |
$483.78 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
12 |
12 |
$449.88 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
360 |
332 |
$436.56 |
| 86900 |
|
262 |
212 |
$432.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
109 |
94 |
$417.01 |
| 86901 |
|
264 |
213 |
$416.38 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
12 |
12 |
$394.08 |
| 85379 |
|
75 |
66 |
$366.89 |
| 0450 |
Emergency room services |
14 |
12 |
$345.70 |
| 85384 |
|
74 |
65 |
$343.28 |
| 86780 |
|
355 |
322 |
$341.02 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
732 |
685 |
$336.30 |
| 87631 |
|
14 |
12 |
$321.12 |
| 83615 |
|
107 |
96 |
$311.62 |
| 85027 |
|
277 |
241 |
$306.88 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
18 |
17 |
$289.52 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
114 |
113 |
$269.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
130 |
128 |
$257.40 |
| 82948 |
|
109 |
87 |
$254.09 |
| 73140 |
|
19 |
17 |
$236.47 |
| 82570 |
|
257 |
229 |
$236.24 |
| 87486 |
|
12 |
12 |
$222.27 |
| 87581 |
|
12 |
12 |
$222.27 |
| 73560 |
|
14 |
13 |
$221.13 |
| 81003 |
|
285 |
261 |
$182.00 |
| 80061 |
Lipid panel |
581 |
544 |
$177.27 |
| 84550 |
|
82 |
72 |
$160.15 |
| 82728 |
|
54 |
51 |
$154.82 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
127 |
126 |
$138.95 |
| 84439 |
|
73 |
70 |
$122.53 |
| 86140 |
|
53 |
53 |
$106.32 |
| 82607 |
|
47 |
43 |
$96.71 |
| 83721 |
|
673 |
543 |
$86.60 |
| 29065 |
|
16 |
13 |
$77.00 |
| 84156 |
|
46 |
40 |
$70.21 |
| 88142 |
|
197 |
187 |
$58.86 |
| J3490 |
Unclassified drugs |
86 |
64 |
$58.10 |
| 87210 |
|
32 |
31 |
$48.54 |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
13 |
13 |
$41.79 |
| 83540 |
|
29 |
27 |
$35.11 |
| 81025 |
|
14 |
14 |
$33.99 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$33.65 |
| 85652 |
|
15 |
15 |
$21.74 |
| 87340 |
|
15 |
12 |
$20.46 |
| 83735 |
|
48 |
42 |
$17.51 |
| 82043 |
|
128 |
115 |
$11.44 |
| 0270 |
|
130 |
112 |
$10.06 |
| 87081 |
|
13 |
13 |
$8.40 |
| 3044F |
|
554 |
550 |
$0.00 |
| 3074F |
|
106 |
99 |
$0.00 |
| 1036F |
|
166 |
147 |
$0.00 |
| 99402 |
|
100 |
100 |
$0.00 |
| 82274 |
|
80 |
75 |
$0.00 |
| 3046F |
|
15 |
15 |
$0.00 |
| 3078F |
|
101 |
94 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
32 |
32 |
$0.00 |
| 84100 |
|
13 |
12 |
$0.00 |